Best Immunotherapy doctors in Israel: TOP 22 doctors

Dr. Pelles Sharon specializes in immunotherapy, including treatments like Keytruda, at Sourasky Medical Center (Ichilov).

• Experienced in various cancer treatments with a focus on immunotherapy
• Contributed to clinical research on oncologic patients' attitudes towards trials
• Performs advanced procedures like Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
• Offers targeted therapies alongside traditional cancer treatments

Prof. Merimsky leads immunotherapy research at Sourasky Medical Center, with decades of expertise in advanced cancer treatments.

• Head of the Unit for Soft Tissue and Bone Oncology
• Faculty member at European Society of Medical Oncology (ESMO) Sarcoma group
• Extensive research collaborations with Weizmann Institute and Felsenstein Medical Research Center
• Over 41 years of experience' experience in clinical oncology practice

Dr. Sarid, a senior oncologist at Ichilov, specializes in biological cancer therapy with over 30 published articles on cancer treatments.

• Over 38 years of experience as a senior oncologist at Sourasky Medical Center
• Principal investigator in clinical trials for cancer therapies
• Specialty training in cancer urology from Oxford University
• Member of ESMO and ASCO – leading oncology organizations

Specialist in Oncological Gynecology and Radiotherapy – Dr. Sapra brings focused expertise to immunotherapy cases at Sourasky Medical Center.

• Specializes in gynecological oncology treatments
• Expertise in radiotherapy applications
• Practices at a leading medical center in Israel

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Prof. Amit Tirosh leads the Neuroendocrine Tumors Service at Sheba Medical Center, specializing in complex hereditary syndromes.

• Expert in Peptide Receptor Radionuclide Therapy (PRRT)
• Head of the Endocrine Oncology Bioinformatics Laboratory
• Affiliated with NIH for MEN1 syndrome research
• Author of 40+ publications on neuroendocrine tumors
• Part of international expert panels on VHL disease

Dr. Ido Wolf leads the Medical Oncology Division at Sourasky Medical Center, specializing in immunotherapy.

• Head of Medical Oncology Division at Sourasky Medical Center
• Degree from Ben Gurion University of the Negev
• Experience in Oncology, Internal Medicine, and Army Medical Units

Leading immunotherapy trials at Sourasky Medical Center – Dr. Raphael specializes in genomic profiling and intra-tumoral injections for thoracic cancers.

• Principal investigator for multiple immunotherapy clinical trials, including pembrolizumab studies
• Expert in liquid biopsies and T-cell repertoire sequencing for treatment response
• Molecular Tumor Board moderator for the Israeli Lung Cancer Society
• Honored as Outstanding Teacher at Tel-Aviv University's medical faculty
• Fellowship-trained in Innovation and Entrepreneurship in Medicine and Health-Tech

Director of Neuro-oncology Service with 30 years of experience specializing in brain tumors. Dr. Blumenthal leads immunotherapy programs at Sourasky Medical Center.

• Trained at Memorial Sloan-Kettering Cancer Center
• Former director at Huntsman Cancer Institute
• Specializes in advanced neuro-oncology treatments

Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky leads immunotherapy research and treatment at Ichilov.

• 26 years of experience specializing in oncology
• Primary researcher in phase 1-3 clinical trials
• Trained at Tel Aviv Medical Center
• Expert in internal medicine and oncology

Dr. Dror Levin is a leading expert in pediatric hematology oncology, specializing in bone cancer (sarcoma) treatment for children at Sourasky Medical Center in Tel Aviv.

• Director of children's hematology oncology department at Sourasky Medical Center
• Specialized in pediatric hematology and oncology at Schneider Children's Medical Center
• Member of the Israeli association for pediatric hemato-oncology (ISPHO)
• Trained in bone and soft tissue oncology at Rizzoli Orthopaedic Institute in Italy

Dr. Fredi Aviv brings 34 years of experience of specialized experience in oncohematology at Sourasky Medical Center (Ichilov Clinic).

• Specializes in immunotherapy treatments for blood cancers
• Extensive experience with complex hematologic malignancies
• Practices at one of Israel's leading medical centers

Dr. Amir specializes in targeted therapy with Keytruda (Pembolizumab) for breast cancer, with over 30 presentations at scientific meetings.

• Recipient of multiple awards, including ESMO Breast Cancer Translational Research Award
• Member of European Society of Medical Oncology (ESMO)
• Fellowship in Breast Cancer Research at Emory University
• Over 19 years of experience of experience in oncology

Prof. Ben Boursi leads groundbreaking research on microbiome's role in cancer therapy – his work is published in Science and featured at ASCO.

• Specializes in gastrointestinal oncology at Sheba Medical Center
• Trained at University of Pennsylvania and top US cancer centers
• Founder of ECOG-ACRIN Microbiome Working Group
• Develops predictive models for early cancer detection
• Board-certified in both Internal Medicine and Medical Oncology

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.

Chief Physician of the Oncology Center at Assuta Medical Center, Dr. Tepper specializes in immunotherapy treatments.

• Years of experience in oncology with a focus on innovative therapies
• Leads dedicated teams for personalized treatment plans
• Actively involved in advancing immunotherapy protocols

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.